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a  b  s  t  r  a  c  t
Neonatal septicemia is the most important cause of neonatal mortality. A wide variety of
bacteria both aerobic and anaerobic can cause neonatal sepsis. Genus Pantoea is a member
of  Enterobacteriaceae family that inhabits plants, soil and water and rarely causes human
infections,  however, Pantoea dispersa has not been reported as a causative organism for
neonatal  sepsis. We  hereby report two neonates with early onset sepsis caused by PantoeaKeywords:
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Pantoea  dispersa
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dispersa.  Early detection and appropriate antibiotic therapy can improve overall outcome
of  this rare infection in neonates.
culture  report showed Pantoea dispersae organism by auto-
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Neonatal septicemia is the most important cause of morbid-
ity  and mortality among neonates worldwide. A wide variety
of  bacteria both aerobic and anaerobic can cause neonatal
sepsis.1 Genus Pantoea is a member of Enterobacteriaceae fam-
ily  that inhabits plants, soil and water.2 Pantoea agglomerans,
member of this family, has previously been reported pre-
senting  as severe neonatal sepsis,3 however, Pantoea dispersa
has  not been reported as a causative organism for neonatal
sepsis.  We  hereby report two neonates with early onset sepsis
caused  by Pantoea dispersa.
Case  presentation  1
A term, male baby presented at 48 h of life with excessive
cry,  abnormal body movements and poor feeding. The baby
was  delivered by cesarean section due to breech presentation
with  3060 g birth weight and cried immediately after birth.
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Este é um artigo Open Access sob a licençaAntenatal period was  uneventful and mother had no risk fac-
tors  for sepsis. Breastfeeding was  started on day 1 of life and
the  baby accepted feeds well. At admission, the baby was
sick  looking, febrile and had hypoglycemic seizures (blood
sugar  35 mg/dL by dextrostix), which responded to dextrose
bolus.  Sepsis screen was positive with total leukocyte count
4500  mm−3 and C-reactive protein 8 mg/dL. The baby also had
thrombocytopenia (platelet count 80,000 mm−3) at admission.
CSF  examination, serum electrolytes and renal and liver func-
tion  tests were normal (Table 1). The baby was started on
ﬁrst  line antibiotics (piperacillin-tazobabctam with amikacin)
along  with glucose infusion rate at 8 mg/kg/min. However,
upper  gastrointestinal bleeding started at 36 h of life with
worsening of thrombocytopenia (platelet count 24,000 mm−3),
following  which antibiotics were upgraded to meropenem and
amikacin  and platelet concentrate was transfused, after which
bleeding  stopped. Coagulation proﬁle was normal. Blood Institute of Medical Sciences, Indore-Ujjain Highway, Indore,
mated  Bact/Alert 3D system, which was  sensitive to amikacin,
cefepime, ceftriaxone, ciproﬂoxacin, meropenem and aztre-
onam,  and resistant to cefazolin. Meropenem and amikacin
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Table 1 – Initial investigations in both babies.
Case 1 Case 2
Sepsis screen
TLC  (mm−3) 4500 8400
ANC (mm−3) 2400 5400
CRP (dL−1) 8 6
Micro-ESR (mm at 1 h) 8 5
I:T ratio 0.16 0.14
Hb (g/dL) 15 18.9
Platelet count (mm−3) 80,000 165,000
Sodium (mequiv./L) 145 137
Potassium (mequiv./L) 4.3 4.2
Blood urea (mg/dL) 24 18
Serum creatinine (mg/dL) 0.8 1.0
CSF
Cytology 02 (100% Lymphocytes) 04 (100% lymphocytes)
Sugar (mg/dL) 23 (RBS 60) 48 (RBS 65)
Protein  (mg/dL) 60 36
Blood culture Pantoea  dispersa Pantoea dispersa
Chest-X-ray Normal RDS Stage II
USG skull Normal Intraventricular hemorrhage
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TTLC, total leukocyte count; ANC, absolute neutrophil count; CRP, C-re
total cell ratio; CSF, cerebrospinal ﬂuid; RBS, random blood sugar; RD
ere  continued for 14 days. Platelet counts gradually improved
nd  feeds were  started on day 5 of life, with good tolerance.
ltrasonography of skull and abdomen were  normal and the
aby  was  discharged after 14 days of antibiotic therapy. At one
onth follow up, the baby was  doing well and was gaining
eight  normally.
ase  presentation  2
reterm (31 weeks), male baby was  born by cesarean section
or  fetal distress with birth weight of 1210 g. The baby cried
mmediately after birth and apgar scores were  7 and 8, at 1 and
 min, respectively. The mother had history of vaginal leaking
or  24 h prior to delivery, but there was  no history of mater-
al  fever, foul smelling liquor or pelvic tenderness. The baby
ad  respiratory distress and grunting at birth with Silverman
core  6/10, for which he was  transferred to neonatal intensive
are  unit and put on nasal CPAP. Chest X-ray was  suggestive
f  respiratory distress syndrome stage II, however, respiratory
istress  gradually improved on CPAP. Sepsis screen was  nega-
ive  at 6 h. The baby was  started on maintenance ﬂuid and ﬁrst
ine antibiotics (ampicillin–sulbabctam and amikacin) in view
f  positive risk factors for sepsis. However, the baby started
eteriorating after 12 h of life and had intracranial bleed and
hock.  His hematocrit decreased from 61% to 45% and platelet
ount  decreased to 48,000 mm−3. Packed red blood cell and
latelet  concentrates were transfused and vasopressors were
tarted.  Despite aggressive respiratory and vasopressor sup-
ort,  the baby expired at 24 h of life. Blood culture report
evealed growth of Pantoea dispersa organism by Bact/Alert
D  and Vi-Tech2 system, which was  sensitive to amikacin,
efepime, ceftriaxone, ciproﬂoxacin, meropenem and aztre-
nam,  and resistant to cefazolin.
A search for common source of the infection was  initiated.
he  mother of second case had positive risk factors for sepsis; protein; ESR, erythrocyte sedimentation rate; I:T ratio, immature to
piratory distress syndrome.
however, Pantoea dispersa is not a common human pathogen.
Both  babies were delivered in the same operation theater via
cesarean  section within a gap of 15 days; hence, cultures
were sent from operation theater, which were  all negative for
Pantoea species. However, common source infection from oper-
ation  theater was still suspected and operation theater was
thoroughly  fumigated after isolation of this organism. Over
the  last eight months following fumigation, no further case of
Pantoea  species sepsis has been reported from our microbiol-
ogy  laboratory.
Discussion
The genus Pantoea belongs within the family Enterobacteri-
aceae and was  proposed by Gavini et al. This complex covered
many  phena and genomic groups, some of which were  later
designated  as new genera.2 Seven Pantoea species are cur-
rently  distinguished: P. agglomerans, the prototype species of
the  genus; Pantoea ananatis; Pantoea stewartii (divided into the
two  subspecies Pantoea stewartii subsp. stewartii, and Pantoea
stewartii  subsp. indologenes); Pantoea dispersa; Pantoea citrea; Pan-
toea punctata; and Pantoea terrea. These species are generally
associated with plants, either as epiphytes or as pathogens,
and  some species can cause disease in humans.4
Pantoea agglomerans (formerly Enterobacter agglomerans) is a
gram-negative aerobic bacillus in the family Enterobacteriaceae.
All species of the genus Pantoea can be isolated from feculent
material,  plants, and soil, where they can either be pathogens
or  commensals. Within the genus, P. agglomerans is the most
commonly  isolated species in humans, resulting in soft tis-
sue  or bone/joint infections following penetrating trauma by
5vegetation. As an opportunistic human pathogen, P. agglom-
erans  can occur sporadically or in outbreaks. At the beginning
of  the 1970s, P. agglomerans (then called Enterobacter agglom-
erans)  was  implicated in a large U.S. and Canadian outbreak
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of septicemia caused by contaminated closures on bottles of
infusion  ﬂuids; 25 hospitals were involved, with 378 cases.
Since  then, P. agglomerans bacteremia has also been described
in  association with the contamination of intravenous ﬂuid,
parenteral  nutrition, the anesthetic agent propofol, blood
products,  and transference tubes used for intravenous hydra-
tion.  Infection often occurs after injuries with plant thorns,
wood  slivers, or wooden splinters.4
Neonatal sepsis by Pantoea species is rarely reported. A
recent  report, which described the clinical picture of an
almost  fatal infection caused by P. agglomerans, was  observed
during  an outbreak caused by contaminated parenteral nutri-
tional  ﬂuids in a Malaysian neonatal intensive care unit in
2005.  Seven of the eight infected neonates succumbed to the
infection  in this outbreak. P. agglomerans was isolated from
cultures  of the infected neonates and it spread by infected par-
enteral  nutrition solutions.6 Two subsequent series afterwards
reported  eight neonates with late onset sepsis due to P. agglom-
erans,  out of which ﬁve survived after appropriate antibiotic
therapy.7,8
Pantoea dispersa has rarely been reported to cause human
infection. In the ﬁrst report, a 71-year old immunocom-
promised female patient with acute myeloid leukemia and
multiple  myeloma developed left focal lesion in lung ﬁelds
with  pleural effusion. Culture of bronchoalveolar lavage in this
patient grew P. dispersa and the patient improved after ade-
quate  antibiotic therapy.9 In another report, two adult patients
developed  joint infection after total joint replacement, and the
joint  ﬂuid culture revealed growth of P. dispersa. Contaminated
sterilized saline used to process Gram stain was  responsible
for  this pseudo-outbreak of P. dispersa.10
However, P. dispersa sepsis has not been reported in neona-
tal  age group till now. Besides, this organism had not been
reported  from India till date. This is the ﬁrst case report of P.
dispersa  presenting as neonatal sepsis from India to the best
of  our knowledge.
The  organism was  a Gram-negative, motile bacillus belong-
ing  to the family of Enterobacteriaceae. Species identiﬁcation
was  done using automated Bact/Alert 3D system and antibi-
otic  susceptibility was  performed on Vi-Tech-2 system.
Conﬁrmation by molecular methods such as PCR could have
been  more  speciﬁc, but they were  not available in the facili-
ties  where the patients received care. In both cases, isolates
showed  in vitro susceptibility to commonly used antibiotics,
had  early onset sepsis, and showed signiﬁcant clinical dete-
rioration.  The ﬁrst baby was  a term baby and improved well
with  antibiotic and supportive therapy. However, the second,
was  a preterm baby with other co-morbidities (respiratory dis-
tress syndrome and intracranial hemorrhage) and succumbed
to  disease despite early initiation of antibiotics.
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To conclude, Pantoea species is a rare cause of neonatal
sepsis. Early detection and appropriate antibiotic therapy can
improve overall outcome.
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